Cite
HARVARD Citation
Yu, L. et al. (2021). Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 398 (10303), pp. 843-855. [Online].